These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22504412)

  • 1. Replication of associations between cytokine and cytokine receptor single nucleotide polymorphisms and measles-specific adaptive immunophenotypic extremes.
    White SJ; Haralambieva IH; Ovsyannikova IG; Vierkant RA; O'Byrne MM; Poland GA
    Hum Immunol; 2012 Jun; 73(6):636-40. PubMed ID: 22504412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination.
    Haralambieva IH; Ovsyannikova IG; Kennedy RB; Vierkant RA; Pankratz VS; Jacobson RM; Poland GA
    Vaccine; 2011 Oct; 29(45):7883-95. PubMed ID: 21875636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR3 and RIG-I gene variants: associations with functional effects on receptor expression and responses to measles virus and vaccine in vaccinated infants.
    Clifford HD; Yerkovich ST; Khoo SK; Zhang G; Upham J; Le Souëf PN; Richmond P; Hayden CM
    Hum Immunol; 2012 Jun; 73(6):677-85. PubMed ID: 22504413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine.
    Haralambieva IH; Ovsyannikova IG; Umlauf BJ; Vierkant RA; Shane Pankratz V; Jacobson RM; Poland GA
    Vaccine; 2011 Nov; 29(48):8988-97. PubMed ID: 21939710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccination.
    Dhiman N; Ovsyannikova IG; Ryan JE; Jacobson RM; Vierkant RA; Pankratz VS; Jacobsen SJ; Poland GA
    Clin Exp Immunol; 2005 Dec; 142(3):498-504. PubMed ID: 16297162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single nucleotide polymorphisms/haplotypes associated with multiple rubella-specific immune response outcomes post-MMR immunization in healthy children.
    Ovsyannikova IG; Salk HM; Larrabee BR; Pankratz VS; Poland GA
    Immunogenetics; 2015 Oct; 67(10):547-61. PubMed ID: 26329766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-nucleotide polymorphism associations in common with immune responses to measles and rubella vaccines.
    Ovsyannikova IG; Salk HM; Larrabee BR; Pankratz VS; Poland GA
    Immunogenetics; 2014 Nov; 66(11):663-9. PubMed ID: 25139337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between cytokine/cytokine receptor single nucleotide polymorphisms and humoral immunity to measles, mumps and rubella in a Somali population.
    Dhiman N; Ovsyannikova IG; Vierkant RA; Pankratz VS; Jacobson RM; Poland GA
    Tissue Antigens; 2008 Sep; 72(3):211-20. PubMed ID: 18715339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles Virus Neutralizing Antibody Response, Cell-Mediated Immunity, and Immunoglobulin G Antibody Avidity Before and After Receipt of a Third Dose of Measles, Mumps, and Rubella Vaccine in Young Adults.
    Fiebelkorn AP; Coleman LA; Belongia EA; Freeman SK; York D; Bi D; Kulkarni A; Audet S; Mercader S; McGrew M; Hickman CJ; Bellini WJ; Shivakoti R; Griffin DE; Beeler J
    J Infect Dis; 2016 Apr; 213(7):1115-23. PubMed ID: 26597262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine.
    Haralambieva IH; Ovsyannikova IG; O'Byrne M; Pankratz VS; Jacobson RM; Poland GA
    Vaccine; 2011 Jun; 29(27):4485-91. PubMed ID: 21539880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between measles vaccine immunity and single-nucleotide polymorphisms in cytokine and cytokine receptor genes.
    Dhiman N; Ovsyannikova IG; Cunningham JM; Vierkant RA; Kennedy RB; Pankratz VS; Poland GA; Jacobson RM
    J Infect Dis; 2007 Jan; 195(1):21-9. PubMed ID: 17152005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between demographic variables and multiple measles-specific innate and cell-mediated immune responses after measles vaccination.
    Umlauf BJ; Haralambieva IH; Ovsyannikova IG; Kennedy RB; Pankratz VS; Jacobson RM; Poland GA
    Viral Immunol; 2012 Feb; 25(1):29-36. PubMed ID: 22239234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of CD46, SLAM and CD209 cellular receptor gene SNPs with variations in measles vaccine-induced immune responses: a replication study and examination of novel polymorphisms.
    Ovsyannikova IG; Haralambieva IH; Vierkant RA; O'Byrne MM; Jacobson RM; Poland GA
    Hum Hered; 2011; 72(3):206-23. PubMed ID: 22086389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between markers of cellular and humoral immunity to rubella virus following a third dose of measles-mumps-rubella vaccine.
    Crooke SN; Ovsyannikova IG; Kennedy RB; Warner ND; Poland GA
    Vaccine; 2020 Nov; 38(50):7897-7904. PubMed ID: 33158591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential durability of immune responses to measles and mumps following MMR vaccination.
    Kennedy RB; Ovsyannikova IG; Thomas A; Larrabee BR; Rubin S; Poland GA
    Vaccine; 2019 Mar; 37(13):1775-1784. PubMed ID: 30797639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine.
    Ovsyannikova IG; Pankratz VS; Vierkant RA; Jacobson RM; Poland GA
    J Infect Dis; 2006 Mar; 193(5):655-63. PubMed ID: 16453260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.
    Parment PA; Svahn A; Rudén U; Bråkenhielm G; Storsaeter J; Akesson L; Linde A
    Scand J Infect Dis; 2003; 35(10):736-42. PubMed ID: 14606613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA supertypes and immune responses to measles-mumps-rubella viral vaccine: findings and implications for vaccine design.
    Ovsyannikova IG; Jacobson RM; Vierkant RA; Pankratz VS; Poland GA
    Vaccine; 2007 Apr; 25(16):3090-100. PubMed ID: 17280755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in the Wilms Tumor Gene Are Associated With Interindividual Variations in Rubella Virus-Specific Cellular Immunity After Measles-Mumps-Rubella II Vaccination.
    Voigt EA; Haralambieva IH; Larrabee BL; Kennedy RB; Ovsyannikova IG; Schaid DJ; Poland GA
    J Infect Dis; 2018 Jan; 217(4):560-566. PubMed ID: 29253144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.
    Knuf M; Zepp F; Helm K; Maurer H; Prieler A; Kieninger-Baum D; Douha M; Willems P
    Eur J Pediatr; 2012 Mar; 171(3):463-70. PubMed ID: 21935584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.